InVitro International
IVRO · OTC
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | $1,356 | $2,266 | $1,303 | $1,473 |
| - Cash | $665 | $417 | $357 | $1,232 |
| + Debt | $287 | $340 | $44 | $0 |
| Enterprise Value | $978 | $2,189 | $990 | $240 |
| Revenue | $879 | $811 | $793 | $854 |
| % Growth | 8.3% | 2.4% | -7.1% | – |
| Gross Profit | $718 | $653 | $636 | $680 |
| % Margin | 81.7% | 80.6% | 80.2% | 79.7% |
| EBITDA | $129 | $112 | $7 | $16 |
| % Margin | 14.7% | 13.8% | 0.8% | 1.9% |
| Net Income | $122 | $107 | $2 | $21 |
| % Margin | 13.9% | 13.2% | 0.2% | 2.5% |
| EPS Diluted | 0.005 | 0.005 | 0 | 0.001 |
| % Growth | 17.8% | 4,400% | -88.9% | – |
| Operating Cash Flow | -$7 | $99 | -$59 | $41 |
| Capital Expenditures | -$1 | $0 | -$1 | -$9 |
| Free Cash Flow | -$9 | $99 | -$60 | $31 |